Regeneron Pharmaceuticals Inc. buy Luise1
Start price
21.06.15
/
50%
€463.80
Target price
21.12.15
€550.50
Performance (%)
9.26%
End price
21.12.15
€506.77
Summary
This prediction ended on 21.12.15 with a price of €506.77. The BUY prediction by Luise1 finished with a performance of 9.26%. Luise1 has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 1.360% | 1.360% | 42.407% | -6.288% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
Comments by Luise1 for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Biotech
ein spekulatives buy
(Laufzeit überschritten)